JTCS St. Jude Medical
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mazhar Ur Rehman
Levent Guvendik
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alex, J.
Right arrow Articles by Guvendik, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alex, J.
Right arrow Articles by Guvendik, L.
Related Collections
Right arrow Cardiac - other

J Thorac Cardiovasc Surg 2004;128:326-327
© 2004 The American Association for Thoracic Surgery


Letter to the editor

Ventral cardiac denervation: Is it truly an effective prophylaxis against atrial fibrillation after coronary artery bypass grafting?

Joseph Alex, MBBS, MRCS, Mazhar Ur Rehman, MBBS, FRCS (CTh), Levent Guvendik, MD, FRCS, FETCS

Department of Cardiothoracic Surgery, Castle Hill Hospital, Hull And East Yorkshire Hospitals NHS Trust, Hull, United Kingdom

The first 20% of the full text of this article appears below.

To the Editor:

We read with interest the article by Melo and colleagues1 on ventral cardiac denervation (VCD) as a prophylaxis against atrial fibrillation (AF) after coronary revascularization. However, we wish to point out certain aspects of the methodology that may have affected the results. Post-CABG AF is paroxysmal in a large proportion of patients and does not always give rise to clinical symptoms. The fact that only 34% and 33% of the patients in their VCD and control groups, respectively, had continuous telemetry monitoring for 4 days would have significantly reduced the AF detection rate, the primary end point of the study. Although statistically nonsignificant, . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The American Association for Thoracic Surgery.